<!DOCTYPE html>
<html  lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
  <head>
    <meta charset="utf-8" />
<script async src="https://www.googletagmanager.com/gtag/js?id=UA-22737364-1"></script>
<meta property="og:site_name" content="U.S. Food and Drug Administration" />
<meta name="twitter:card" content="summary_large_image" />
<meta name="dcterms.title" content="FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)" />
<meta property="og:type" content="Article" />
<meta name="dcterms.creator" content="Center for Drug Evaluation and Research" />
<meta name="twitter:site" content="@US_FDA" />
<meta name="description" content="[07-29-2010] The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug." />
<meta name="twitter:title" content="Eosinophilic pneumonia associated with the use of Cubicin" />
<meta property="og:url" content="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" />
<meta name="google-site-verification" content="tWxlDhm4ANdksJZPj7TBmHgNoMqZCnecPp0Aa2vC9XA" />
<meta property="og:title" content="Eosinophilic pneumonia associated with the use of Cubicin" />
<meta name="twitter:creator" content="@US_FDA" />
<meta name="dcterms.description" content="[07-29-2010] The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug." />
<meta name="dcterms.publisher" content="FDA" />
<meta name="dcterms.audience" content="Health Care Provider" />
<meta name="dcterms.type" content="Article" />
<meta name="dcterms.source" content="FDA" />
<meta property="og:updated_time" content="Thu, 08/03/2017 - 05:28" />
<meta property="article:publisher" content="FDA" />
<meta property="article:published_time" content="Fri, 06/28/2019 - 08:56" />
<meta property="article:modified_time" content="Thu, 08/03/2017 - 05:28" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<script type="application/ld+json">{
    "@context": "https://schema.org",
    "@graph": [
        {
            "@type": "Article",
            "headline": "FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)",
            "name": "FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)",
            "description": "[07-29-2010] The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug.",
            "image": {
                "@type": "ImageObject",
                "representativeOfPage": "True"
            },
            "datePublished": "Fri, 06/28/2019 - 08:56",
            "dateModified": "Thu, 08/03/2017 - 05:28",
            "author": {
                "@type": "Organization",
                "name": "Center for Drug Evaluation and Research"
            },
            "publisher": {
                "@type": "Organization",
                "name": "FDA"
            }
        },
        {
            "@type": "WebSite"
        }
    ]
}</script>
<meta property="og:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" />
<meta name="twitter:image" content="https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png" />
<meta property="og:description" content="[07-29-2010] The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug." />
<meta property="twitter:description" content="[07-29-2010] The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug." />
<link rel="shortcut icon" href="/themes/custom/preview/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" hreflang="en" href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" />
<link rel="canonical" href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" />
<link rel="shortlink" href="https://www.fda.gov/node/361263" />
<link rel="revision" href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" />

    <title>FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin) | FDA</title>
    <link rel="stylesheet" media="all" href="/files/css/css_APbBjJUvRMUe90sxb9w7gY54PYttoAPSo1_7dhmSUwo.css" />
<link rel="stylesheet" media="all" href="/files/css/css_66lZy6YfefbOUiGMZAyKDZ_f3jh6ZMlZzGfmMYKyHMw.css" />

    
<!--[if lte IE 8]>
<script src="/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->
<script src="https://script.crazyegg.com/pages/scripts/0024/3700.js" async></script>
<script src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&amp;subagency=FDA&amp;sdor=fda.gov&amp;dclink=true" language="javascript" id="_fed_an_ua_tag"></script>

            <script>window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments)};gtag("js", new Date());gtag("config", "UA-22737364-1", {"groups":"default","anonymize_ip":true,"allow_ad_personalization_signals":false});</script>
        
  </head>
  <body class="role-anonymous path-node page-node-type-article has-glyphicons">
      <div id="quicklinks" class="sr-only">
        <ul>
          <li><a href="#main-content" class="sr-only sr-only-focusable" tabindex="1">Skip to main content</a></li>
          <li><a href="#search-form" class="sr-only sr-only-focusable" tabindex="1">Skip to FDA Search</a></li>
          <li><a href="#section-nav" class="sr-only sr-only-focusable" tabindex="1">Skip to in this section menu</a></li>
          <li><a href="#footer-heading" class="sr-only sr-only-focusable" tabindex="1">Skip to footer links</a></li>
        </ul>   
      </div>    
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
     
  <div class="main-container container-fluid">     <div class="row">
                                                               



	
	<header class="lcds-header container-fluid" role="header">
		
			<div class="row us-masthead"> 

				<div class="usa-banner col-xs-12">

					<img class="usa-banner__us-flag" src="/themes/custom/preview/assets/images/US_Flag.png" alt="U.S. flag" />

					<span>An official website of the United States government</span>

					<a id="USMenuButton" class="collapsed" data-toggle="collapse" data-target="#USABannerMenu" aria-expanded="false" aria-controls="USABannerMenu">HereвЂ™s how you know <span class="toggle-indicator"> </span></a>
          			<div class="col-xs-12 collapse usa-banner__menu" id="USABannerMenu" aria-labelledby="USMenuButton">


						<div id="gov-banner" class="row usa-banner-content usa-grid usa-accordion-content" aria-hidden="true">
							      <div class="col-xs-12 col-sm-6 col-md-3">
							        <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-dot-gov.svg" alt="Dot gov" style="width:3em;">
									<div class="usa-media_block-body">
								      <p><strong>The .gov means itвЂ™s official.</strong><br>Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.</p>
								    </div>
							      </div>
							      <div class="col-xs-12 col-sm-6 col-md-3">
							        <img class="usa-banner-icon usa-media_block-img" src="/themes/custom/preview/assets/images/icon-https.svg" alt="SSL" style="width:3em;">
							        <div class="usa-media_block-body">
								         <p><strong>The site is secure.</strong><br> The <strong>https://</strong> ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.</p>
							        </div>
							      </div>
						</div>
					</div>

				</div>
			</div> 
			<div class="row fda-masthead">
							<div class="col-xs-4 col-md-8"> 
					<a href="/" title="FDA Homepage">
						<h1 class="fda-masthead__fda-logo">U.S. Food and Drug Administration</h1>
					</a>
       	</div>
				
        <div class="col-xs-8 col-md-4">
          <ul class='fda-masthead__item-list'>
            <li><a title="" id="btn-search" class="btn btn-default btn-sm fda-masthead__btn-search">
              <span class="fa fa-search" aria-hidden="true">&nbsp;</span>
              <span class="fda-masthead__btn-label">Search</span>
            </a></li>
            <li><a id="menu-btn" class="btn btn-default btn-sm fda-masthead__btn-menu collapsed" href="#primary-nav" data-toggle="collapse" aria-expanded="true">
              <span class="fa fa-bars" aria-hidden="true">&nbsp;</span>
              <span class='fda-masthead__btn-label'>Menu</span>
            </a></li>
          </ul>
				</div>
							
						<form class="fda-masthead__search sr-only" role="search" action="https://search.usa.gov/search" method="GET" name="searchForm" id="search-form" accept-charset="UTF-8" >
							
							<div class="search-popover" id="search-popover">
								<div class="input-group pull-right" id="search-group">
									<label class="sr-only" for="search-query">Search FDA</label>
									
									<input accesskey="4" class="form-control search-input" id="search-query" name="query" aria-autocomplete="list" aria-haspopup="true" title="Enter the terms you wish to search for." placeholder="Search FDA"  type="text" /> 
									
									<span class="input-group-btn" id="input-group-btn">
										
										<button type="submit" class="btn btn-danger search-btn" id="search-btn" title="Search"><span class="fa fa-search" aria-hidden="true"><span class="sr-only">Submit search</span></span></button>

									</span>

								</div>
							</div>
														
							<input name="affiliate" value="fda1" type="hidden">							
						</form>					

			</div> 
		<nav id="primary-nav" class="lcds-primary-nav row collapse">					<div class="col-md-5 col-lg-4">
						<section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
							<h2 class="lcds-primary-nav__group-heading">Featured</h2>
							<ul class="lcds-primary-nav__list lcds-primary-nav__list--featured">
	                <li class="lcds-primary-nav__list-item"><a href="/about-fda/contact-fda">Contact FDA</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/regulatory-information/search-fda-guidance-documents">FDA Guidance Documents</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/safety/recalls-market-withdrawals-safety-alerts">Recalls, Market Withdrawals and Safety Alerts</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/news-events/newsroom/press-announcements">Press Announcements</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters">Warning Letters</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/advisory-committees">Advisory Committees</a></li>
	                <li class="lcds-primary-nav__list-item"><a href="/about-fda/en-espanol">En Espa&#241ol</a></li>
							</ul>
						</section>
					</div>

					<div class="col-md-7 col-lg-8">
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Products</h2>
            <ul class="lcds-primary-nav__list">
							<li class="lcds-primary-nav__list-item"><a href="/food">Food</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/drugs">Drugs</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/medical-devices">Medical Devices</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/radiation-emitting-products">Radiation-Emitting Products</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/vaccines-blood-biologics">Vaccines, Blood, and Biologics</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/animal-veterinary">Animal and Veterinary</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/cosmetics">Cosmetics</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/tobacco-products">Tobacco Products</a></li>
            </ul>
          </section>
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Topics</h2>
            <ul class="lcds-primary-nav__list">
							<li class="lcds-primary-nav__list-item"><a href="/about-fda">About FDA</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/combination-products">Combination Products</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/regulatory-information">Regulatory Information</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/safety">Safety</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/emergency-preparedness-and-response">Emergency Preparedness</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/international-programs">International Programs</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/news-events">News and Events</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/training-and-continuing-education">Training and Continuing Education</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/inspections-compliance-enforcement-and-criminal-investigations">Inspections and Compliance</a></li>
							<li class="lcds-primary-nav__list-item"><a href="/science-research">Science and Research</a></li>
            </ul>
          </section>
          <section class="lcds-primary-nav__group lcds-primary-nav__group--bordered">
            <h2 class="lcds-primary-nav__group-heading">Information For</h2>
            <ul class="lcds-primary-nav__list">
	            <li class="lcds-primary-nav__list-item"><a href="/consumers">Consumers</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/patients">Patients</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/industry">Industry</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/health-professionals">Health Professionals</a></li>
	            <li class="lcds-primary-nav__list-item"><a href="/federal-state-local-tribal-and-territorial-officials">Federal, State and Local Officials</a></li>
            </ul>
          </section>
					</div>
	      </nav>
    </header>

<div class="col-xs-12">
	<div data-drupal-messages-fallback class="hidden"></div>

</div>

                              
                                                                     <section id="block-entityviewcontent" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

<a class="lcds-button--expandable collapsed hidden-md hidden-lg" data-toggle="collapse" href="#section-nav" >In this section<span class="visible-sm-inline-block">:

                Postmarket Drug Safety Information for Patients and Providers
    
    </span>
</a>

<nav id="section-nav" class="lcds-card lcds-section-nav lcds-section-nav hidden-md hidden-lg collapse">

    <ul class="lcds-section-nav__list">

      <li>

              <a href="/drugs/drug-safety-and-availability/postmarket-drug-safety-information-patients-and-providers" title="Postmarket Drug Safety Information for Patients and Providers" class="lcds-section-nav__section-link lcds-section-nav__link lcds-section-nav__parent-link visible-xs-block visible-sm-block">
                                        Postmarket Drug Safety Information for Patients and Providers
                    </a>

                        <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_5 js-view-dom-id-28a541ffe52e8ae1a744e71118260aa7ad10ba4da83587dda081987cfd4e1e3c">
  
    
      
  
      <div>
  
  <ul class="lcds-section-nav__section-link__active lcds-section-nav__list">

          <li><a href="/drugs/postmarket-drug-safety-information-patients-and-providers/index-drug-specific-information" class="lcds-section-nav__link">Index to Drug-Specific Information</a></li>
    
  </ul>

</div>


  
          </div>
</div>


                        <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_2 js-view-dom-id-9544fefe101a51d2434c42f8194843a09c437b63796868ded3c6f1910b7685cd">
  
    
      
  
          </div>
</div>


      </li>

    </ul>

</nav>

  </section>

<section id="block-entityviewcontent-15" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      
    <ol class="lcds-breadcrumb visible-md visible-lg">
          <li >
                  <a href="/">Home</a>
              </li>
          <li >
                  <a href="/drugs">Drugs</a>
              </li>
          <li >
                  <a href="/drugs/drug-safety-and-availability">Drug Safety and Availability</a>
              </li>
          <li >
                  <a href="/drugs/drug-safety-and-availability/postmarket-drug-safety-information-patients-and-providers">Postmarket Drug Safety Information for Patients and Providers</a>
              </li>
          <li >
                  <a class="current-link">FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)</a>
              </li>
      </ol>




<ol class="lcds-breadcrumb visible-sm visible-xs">
  <li>
    <a href="/drugs/drug-safety-and-availability/postmarket-drug-safety-information-patients-and-providers" title="Postmarket Drug Safety Information for Patients and Providers">
     Postmarket Drug Safety Information for Patients and Providers
    </a>
  </li>
</ol>

  </section>






                                
      <main>

                                 <article id="main-content" class="article main-content container-fluid" role="article">
          
                                                                <header class="row content-header" role="heading">
                         <section id="block-entityviewcontent-2" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      
<div class="col-sm-12 col-md-8 col-md-offset-2">

  <h1 class="content-title text-center">FDA Drug Safety Communication: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)</h1>
  
  	
    <div class="lcds-toolbar lcds-toolbar--social">
      <ul class="lcds-share lcds-share--default">
    <li class="lcds-share__item">
      <a href="https://www.facebook.com/sharer/sharer.php?u=" class="lcds-share__btn lcds-share--default__btn-facebook js-share" id="fb-share" target="_blank"><span class="fa icon-facebook" aria-hidden="true"></span>Share</a>
    </li>
    <li class="lcds-share__item">
      <a href="https://twitter.com/intent/tweet/?text=FDA%20Drug%20Safety%20Communication%3A%20Eosinophilic%20pneumonia%20associated%20with%20the%20use%20of%20Cubicin%20%28daptomycin%29&amp;url=https://www.fda.gov%2Fdrugs%2Fpostmarket-drug-safety-information-patients-and-providers%2Ffda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" target="_blank" class="lcds-share__btn lcds-share--default__btn-twitter js-share" id="twitter-share"><span class="fa icon-twitter" aria-hidden="true"></span>Tweet</a>
    </li>
    <li class="lcds-share__item hidden-xs">
      <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.fda.gov%2Fdrugs%2Fpostmarket-drug-safety-information-patients-and-providers%2Ffda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin&amp;title=FDA%20Drug%20Safety%20Communication%3A%20Eosinophilic%20pneumonia%20associated%20with%20the%20use%20of%20Cubicin%20%28daptomycin%29&amp;source=FDA" class="lcds-share__btn lcds-share--default__btn-linkedin js-share" id="linkedin-share" target="_blank"><span class="fa icon-linkedin" aria-hidden="true"></span>Linkedin</a>
    </li>

    <li class="lcds-share__item">
      <a href="mailto:?subject=FDA%20Drug%20Safety%20Communication%3A%20Eosinophilic%20pneumonia%20associated%20with%20the%20use%20of%20Cubicin%20%28daptomycin%29&amp;body=https://www.fda.gov%2Fdrugs%2Fpostmarket-drug-safety-information-patients-and-providers%2Ffda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" class="lcds-share__btn lcds-share--default__btn-mail"><span class="fa icon-envelope" aria-hidden="true"></span>Email</a>
      </li>
    <li class=" lcds-share__item hidden-xs">
      <a href="javascript:window.print();" title="Print this page" class="lcds-share__btn lcds-share--default__btn-print"><span class="fa icon-print" aria-hidden="true"></span>Print</a>
    </li>
  </ul>
  <div class="form-group">
    
  </div>
</div>
 
</div>

  </section>






                      </header>
                              
                                                                           <div class="col-md-8 col-md-push-2" role="main">

                            
                            
                            
                            
                                              
  
<p><b><a href="#sa">Safety Announcement</a></b><br /><b><a href="#aip">Additional Information for Patients</a></b><br /><b><a href="#aihp">Additional Information for Healthcare Professionals</a></b><br /><b><a href="#ds">Data Summary</a> </b></p>

<p><b>Safety Announcement<a name="sa" id="sa"></a> </b></p>

<p><strong>[07-29-2010]</strong> The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals about the potential for developing eosinophilic pneumonia during treatment with Cubicin (daptomycin), an intravenous antibacterial drug.</p>

<p>Cubicin was first approved in September 2003 to treat serious skin infections. In 2006, it was approved to treat bloodstream infections.</p>

<p>Eosinophilic pneumonia is a rare, but serious condition where a type of white blood cell (eosinophil) fills the lungs. Symptoms of eosinophilic pneumonia include fever, cough, shortness of breath, and difficulty breathing.</p>

<p>Healthcare professionals should closely monitor patients being treated with Cubicin for eosinophilic pneumonia (see <a href="#aihp">Additional Information for Healthcare Professionals</a>). Patients receiving Cubicin should immediately contact their healthcare professional if they develop a new or worsening fever, cough, shortness of breath, or difficulty breathing.</p>

<p>In 2007, pulmonary eosinophilia was added to the <i>Adverse Reactions,</i> <i>Post-Marketing Experience</i> section of the Cubicin product label. Since then, the Agency has reviewed published case reports of Cubicin-associated eosinophilic pneumonia,<sup>1-4</sup> and conducted a review of post-marketing adverse event reports from the FDA's Adverse Event Reporting System (AERS). FDA's review identified 7 cases of eosinophilic pneumonia between 2004 and 2010 that were most likely associated with Cubicin (see <a href="#ds">Data Summary </a>below).</p>

<p>Based on these reviews, FDA determined that eosinophilic pneumonia can be associated with Cubicin use and requested that the manufacturer of Cubicin include this information in the <i>Warnings and Precautions</i> and <i>Adverse Reactions, Post-Marketing Experience</i> sections of the drug label.</p>

<p><b>Additional Information for Patients<a name="aip" id="aip"></a></b></p>

<ul type="disc"><li>Be aware that eosinophilic pneumonia has been reported in patients receiving Cubicin.</li>
	<li>If you experience a new or worsening fever, cough, shortness of breath, or have difficulty breathing while receiving Cubicin, contact your healthcare professional immediately.</li>
	<li>Talk to your healthcare professional about any concerns with Cubicin.</li>
	<li>Report any side effects from the use of Cubicin to the FDA MedWatch program, using the information in the "Contact Us" box at the bottom of the page.</li>
</ul><p><b>Additional Information for Healthcare Professionals<a name="aihp" id="aihp"></a></b></p>

<ul type="disc"><li>Be aware that eosinophilic pneumonia has been reported in patients receiving Cubicin.</li>
	<li>Discuss with patients the clinical benefits and potential risks of Cubicin, including the risk of eosinophilic pneumonia, prior to beginning treatment.</li>
	<li>Monitor patients for signs and symptoms of eosinophilic pneumonia, including new onset or worsening fever, dyspnea, difficulty breathing, and new infiltrates on chest imaging studies.</li>
	<li>In patients exhibiting signs and symptoms of eosinophilic pneumonia, discontinue Cubicin and consider treating as clinically indicated.</li>
	<li>Report adverse events involving Cubicin to the FDA MedWatch program using the information in the "Contact Us" box at the bottom of this page.</li>
</ul><p><b>Data Summary<a name="ds" id="ds"></a></b></p>

<p>FDA identified six cases of eosinophilic pneumonia reported to AERS between 2004 and 2010 that were most likely associated with Cubicin. One additional case of eosinophilic pneumonia most likely associated with Cubicin was identified in the medical literature.<sup>2</sup></p>

<p>For FDA's review, a case of eosinophilic pneumonia most likely associated with Cubicin was defined as meeting all of the following criteria:</p>

<ul type="disc"><li>Concurrent exposure to Cubicin</li>
	<li>Fever</li>
	<li>Dyspnea with increased oxygen requirement or requiring mechanical ventilation</li>
	<li>New infiltrates on chest x-ray or computed tomography scan</li>
	<li>Bronchoalveolar lavage with &gt; 25% eosinophils</li>
	<li>Clinical improvement following Cubicin withdrawal</li>
</ul><p>Of the seven cases identified using the above definition:</p>

<ul type="disc"><li>Cubicin was prescribed for non-FDA approved indications, including osteomyelitis (n=4), prosthetic hip infection (n=1), enterococcal endocarditis (n=1), and aortic valve endocarditis (n=1).</li>
	<li>The ages of patients ranged from 60 to 87 years.</li>
	<li>Eosinophilic pneumonia developed 2-4 weeks after initiating Cubicin treatment.</li>
	<li>All seven cases reported improvement or resolution of symptoms after Cubicin was discontinued. Five of the seven cases were also treated with systemic corticosteroids.</li>
	<li>Two cases reported recurrence of eosinophilic pneumonia after Cubicin was restarted.</li>
</ul><p>FDA also identified 36 possible cases of eosinophilic pneumonia associated with Cubicin use. Although these cases did not meet the full criteria for a likely case of eosinophilic pneumonia associated with Cubicin, they do provide additional support for an association between use of Cubicin and development of eosinophilic pneumonia.</p>

<p>Based on FDA's review, there appears to be a temporal association between Cubicin administration and the development of eosinophilic pneumonia. Eosinophilic pneumonia may lead to progressive respiratory failure and is potentially fatal if not quickly recognized and appropriately managed. FDA requested that Cubist, the manufacturer of the product, revise the <em>Warnings and Precautions</em><em> and Adverse Reaction</em><i>s, Post-Marketing Experience<em> </em></i>sections of the Cubicin product label to further inform healthcare professionals of this association.</p>

<p>References:</p>

<p>1. Lal Y, Assimacopoulos AP. Two cases of daptomycin-induced eosinophilic pneumonia and chronic pneumonitis. <i>Clin</i><i> Infect Dis.</i> 2010;50:737-40.</p>

<p>2. Hayes D Jr, Anstead MI, Kuhn RJ. Eosinophilic pneumonia induced by daptomycin. <i>J Infect.</i> 2007;54:e211-3.</p>

<p>3. Miller BA, Gray A, Leblanc TW, Sexton DJ, Martin AR, Slama TG. Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. <i>Clin</i><i> Infect Dis.</i> 2010;50:e63-8.</p>

<p>4. Kakish E, Wiesner AM, Winstead PS, Bensadoun ES. Acute respiratory failure due to daptomycin induced eosinophilic pneumonia. <i>Respir</i><i> Med CME.</i> 2008;1:235-7.</p>

<p>В </p>

<h2>Related Information</h2>

<ul><li><a href="http://wayback.archive-it.org/7993/20170113084022/http:/www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220282.htm">Daptomycin (marketed as Cubicin) Information</a></li>
	<li><a href="http://wayback.archive-it.org/7993/20170111234124/http:/www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm220936.htm">FDA Drug Safety Podcast for Healthcare Professionals: Eosinophilic pneumonia associated with the use of Cubicin (daptomycin)</a></li>
</ul>



              
                                            
              
            </div>

                                                                                  <aside class="col-md-2 col-md-push-2" role="complementary">
                  <section id="block-entityviewcontent-4" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

<div role="article" about="/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" class="region region-">
  <aside class="lcds-card lcds-card--border-top" role="menu">
    <ul class="lcds-description-list">
      
                            
<div class="node-current-date">
  <li class="lcds-description-list__item">
    <div>
      <h2 class="lcds-description-list__item-heading">Content current as of:</h2>
      <p class="lcds-description-list__item-text"><time datetime="2017-08-03T05:28:00Z">08/03/2017</time>
</p>
    </div>
  </li>
</div>


  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  
              
              
<li class="lcds-description-list__item">  
	<div>
		
		 <h2 class="lcds-description-list__item-heading">Regulated Product(s)</h2>
		 <ul class="lcds-metadata-list">
						  <li>Drugs</li>
			  			     			  						              
			
			
			
			
			
			
			
			
					</ul>
	 
			     
						       

			  
						  

			  
						 
	</div>
</li>   

    </ul>

  </aside>
</div>


  </section>


                </aside>
            

                                                                                <aside class="col-md-2 col-md-pull-10" role="complementary">
                  <section id="block-entityviewcontent-3" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

        <div role="article" about="/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-eosinophilic-pneumonia-associated-use-cubicin-daptomycin" class="region region-">
        <nav id="section-nav"class="lcds-card lcds-section-nav lcds-section-nav--side hidden-xs hidden-sm">
      <ul class="lcds-section-nav__list lcds-section-nav--side__list">
        <li>

                    <a href="/drugs/drug-safety-and-availability/postmarket-drug-safety-information-patients-and-providers" class="lcds-section-nav__link lcds-section-nav--side__link lcds-section-nav__parent-link lcds-section-nav--side__parent-link">
                                        Postmarket Drug Safety Information for Patients and Providers
                      </a>

          
                        <div class="views-element-container form-group"><div class="view view-in-this-section view-id-in_this_section view-display-id-block_4 js-view-dom-id-66187f57ac1ead88430393cf3dac03f6006f7d41c51a2116c7c70d4c0cf67d57">
  
    
      
  
      <div class="item-list">
  
  <ul class="lcds-section-nav__active lcds-section-nav__list lcds-section-nav--side__list">

          <li><a href="/drugs/postmarket-drug-safety-information-patients-and-providers/index-drug-specific-information" class="lcds-section-nav__link lcds-section-nav--side__link">Index to Drug-Specific Information</a></li>
    
  </ul>

</div>


  
          </div>
</div>


                        <div class="views-element-container form-group"><div class="view view-in-this-section-sub view-id-in_this_section_sub view-display-id-block_1 js-view-dom-id-2a3b3f383e6453cda1d2d8aab04c5acf2ddaf6313762fc8d4ac77562a06591b1">
  
    
      
  
          </div>
</div>


        </li>
      </ul>
    </nav>
    </div>

  </section>


                </aside>
            
                 </article>        
      </main>

    </div>  </div>

                <div class="region region-subscribe">
    <section id="block-entityviewcontent-5" data-block-plugin-id="entity_view:node" class="block block-ctools block-entity-viewnode clearfix">
  
    

      

  </section>


  </div>

  
      <footer class="lcds-footer container-fluid">
        
    <div class="row lcds-footer__primary">
    <h2 id="footer-heading" class="sr-only">Footer Links</h2>
    <nav class="text-center">
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/about-fda/about-website/fdagov-archive" >FDA Archive</a></li>
          <li><a href="/about-fda" >About FDA</a></li>
          <li><a href="/about-fda/about-website/internet-accessibility" >Accessibility</a></li>
        </ul>
      </div>
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/about-fda/white-oak-campus-information/public-meetings-fda-white-oak-campus" >Visitor Information</a> </li>
          <li><a href="/about-fda/about-website/website-policies" >Website Policies / Privacy</a></li>
          <li><a href="/about-fda/jobs-and-training-fda/no-fear-act" >No FEAR Act</a></li>
        </ul>
      </div>
      <div class="col-sm-4">
        <ul class="nav">
          <li><a href="/regulatory-information/freedom-information" title="Freedom of Information Act">FOIA</a></li>
          <li><a href="https://www.hhs.gov/" title="Health and Human Services" target="_blank">HHS.gov</a></li>
          <li><a href="https://www.usa.gov/" target="_blank">USA.gov</a></li>
        </ul>
      </div>
    </nav>
  </div>
    <div class="row lcds-footer__secondary">
    <div class=" col-sm-12 col-md-4 lcds-footer__social-links">
      <a href="/about-fda/contact-fda" class="btn btn-default btn-md">Contact FDA</a>

      <a href="https://www.facebook.com/FDA" title="Follow FDA on Facebook" class="no-disclaimer"> 
        <span class="fa fa-facebook fa-2x" aria-hidden="true">
          <span class="sr-only">Follow FDA on Facebook</span> 
        </span>
      </a>
      <a href="https://www.twitter.com/US_FDA" title="Follow FDA on Twitter" class="no-disclaimer"> 
          <span class="fa fa-twitter fa-2x" aria-hidden="true">
             <span class="sr-only">Follow FDA on Twitter</span> 
          </span> 
      </a>
      <a href="https://www.youtube.com/user/USFoodandDrugAdmin" title="View FDA videos on YouTube" class="no-disclaimer">
        <span class="fa fa-youtube fa-2x" aria-hidden="true"> 
          <span class="sr-only">View FDA videos on YouTube</span>
        </span>
      </a>
      <a href="/about-fda/contact-fda/subscribe-podcasts-and-news-feeds" title="Subscribe to FDA RSS feeds">
        <span class="fa fa-rss fa-2x" aria-hidden="true">
          <span class="sr-only">Subscribe to FDA RSS feeds</span>
        </span>
      </a>
    </div>
    <a href="/" title="FDA Homepage">
        <div class="hidden-xs hidden-sm col-md-4 text-center lcds-footer__logo">
        <span class="sr-only">FDA Homepage</span>
        </div>
    </a>

    <div class="col-sm-12 col-md-4 text-center lcds-footer__contact-number">
      <span class="fa fa-phone" aria-hidden="true"> </span> 
     <span class="sr-only">Contact Number</span>
      1-888-INFO-FDA (1-888-463-6332)
    </div>
  </div>
        
    <script type='text/javascript'>
  (function(){var g=function(e,h,f,g){
  this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};
  this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};
  this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};
  this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g+ "&t=" + (new Date()).getTime();document.body&&document.body.appendChild(a)}};
  this.start=function(){var a=this;window.addEventListener?window.addEventListener("load",function(){a.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){a.go()})}};
  try{(new g(100,"r","QSI_S_ZN_6FpQ8uiCQiPh6SN","https://zn6fpq8uicqiph6sn-fdawebcx.gov1.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_6FpQ8uiCQiPh6SN")).start()}catch(i){}})();
  </script><div id='ZN_6FpQ8uiCQiPh6SN'><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div>
  <!--END WEBSITE FEEDBACK SNIPPET-->


    </footer>
    <a href="" id="btn-top" class="btn btn-primary btn-top"><span class="sr-only">Back to </span>Top</a>
  
  </div>

    
    <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/361263","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"jquery":{"ui":{"datepicker":{"isRTL":false,"firstDay":0}}},"fda_ckeditor_enhancements":{"basePath":"modules\/custom\/fda_ckeditor_enhancements"},"google_analytics":{"account":"UA-22737364-1","trackOutbound":true,"trackMailto":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click"},"ajax":[],"user":{"uid":0,"permissionsHash":"2cb8839adccfc95c8211bb4fcc5a0563c1481dd0ce3903a66e3f216728bb3044"}}</script>
<script src="/files/js/js_ModyCU6NkUWRWH6_vXPivXFjDYX0Jyg5QGIIUCtZNBw.js"></script>

  </body>
</html>
